Career Advancement

JULY 1, 2019

For example, a multi-billion-dollar biotechnology company recently contacted me for a training on executive presence to help newly minted high-potential mid-level managers reach the next level of leadership. Here’s the program and what the audience learned.

Training 179

Training Execution Biotechnology Audience 179

Career Advancement

MAY 25, 2021

How can you manage to do it all—without burning out? Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. By doing so, you’ll make your workload more manageable. And yet the U.S.

Tips 156

Tips Biotechnology Objective Learning-by-Doing 156

The Horizons Tracker

NOVEMBER 29, 2023

However, the research also highlights the significance of diverse educational, industrial, and organizational backgrounds among managers and board members in fostering innovation in research and development (R&D), thereby generating both economic and social value.

Diversity 111

Diversity Innovation Biotechnology Short-term 111

Tanveer Naseer

MAY 16, 2011

Russell is an educational psychologist, author, executive coach and management consultant whose clients include Fortune 500 executives in aerospace, healthcare, pharmaceutical and biotechnology, information technology, telecommunications and oil and gas. The following is a guest post by Russell Bishop.

Bureaucracy 233

Bureaucracy Compliance Learning-by-Doing Engineering 233

Career Advancement

SEPTEMBER 27, 2021

How can you manage to do it all—without burning out? Over a five-year span, one of my clients in the biotechnology field kept moving up through the ranks, from manager to senior manager to VP. By doing so, you’ll make your workload more manageable. And yet the U.S.

Tips 120

Tips Biotechnology Objective Learning-by-Doing 120

HR Digest

DECEMBER 2, 2019

The earlier favorites, the Silicon Valley computer geeks, IT guys, and financial and management wizards are facing a downwind due to the economic crisis and the advent of the AI and augmented reality technology, which is changing the modern workplace. The average median salary in the United States is $38,000.

Biotechnology 90

Biotechnology Finance Survey Software 90

Strategy Driven

NOVEMBER 18, 2019

There have also been great leaps forward in biotechnology and even people without investment experience in the industry can find a niche sector to become involved in. This money will need managing and the financial services sector will be there to facilitate this.

Health Care 66

Health Care Biotechnology Energy Insurance 66

Tanveer Naseer

OCTOBER 20, 2015

The first leader was someone I worked with as part of the management team at a biotechnology firm, and how he guided our organization during the merger of our North American parent company with a much larger European multinational.

Power 100

Power Long-term Uncertainty Biotechnology 100

Tanveer Naseer

JUNE 2, 2015

Dan was the president of a biotechnology company where I served in my first middle management role. The reason why I remember these meetings so fondly was because they ended up opening doors to opportunities I had never imagined taking on when I first started in this management role.

Biotechnology 100

Biotechnology Learning-by-Doing Audience Middle Management 100

The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. Bad management? Research created an elaborate robotic system to streamline the user experience for one of the flagship product lines. Sounds like it.

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

The Idolbuster

JANUARY 25, 2013

Prior to launching her wellness practice, she worked in the management consulting industry and at one of the leading cancer research biotechnology companies. Catherine Chen, Ph.D., is a Health Coach who supports high-octane professionals to achieve with ease, have time for what they love, and live a balanced life.

Biotechnology 41

Biotechnology Succession How To Follow-up 41

Strategy Driven

MAY 12, 2021

Drug Research —The applications for drug design and biotechnology using 3D displays can be exponential. He has BS and MBA degrees and a post-graduate diploma in management. One new 3D display has a resolution of 100 million volume pixels or “voxels.” ” Instead of flat square pixels, voxels also have depth.

Technology 98

Technology Content Video Globalization 98

CO2

DECEMBER 15, 2023

Further supporting this, a study published in the National Center for Biotechnology Information (NCBI) emphasizes executive coaching as an effective developmental tool for managers. Schedule a meeting with our Managing Partner. The post Best Executive Coach appeared first on CO2 Coaching.

Executive Coaching 78

Executive Coaching Execution Commitment Skills 78

Skip Prichard

JULY 22, 2019

Let us give you our definition of what it means to be a founder: Playing a central role in starting and managing an initiative that will have impact (preferably visible and large) on an organization or the broader world. ” Management Science 56.2 Paper presented at Academy of Management Meetings. v=HfnFeJlkfZE. [5]

Innovation 83

Innovation Reputation Social Capital How To 83

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. Corporate directors identified talent management as their single greatest strategic challenge. We know that organizations commit enormous resources and effort to talent management, so why aren''t they doing a better job? Not competitive threats.

Talent Management 10

Talent Management Company Telecommunications Management 10

Harvard Business Review

APRIL 8, 2014

For example, if you are a biotechnology fund manager who wants to communicate the importance of investing in biotechnology, you may think that your value is in your recent success in investing for shareholders, but if you are a reasonable person, you will likely also have doubts about this.

Biotechnology 11

Biotechnology Audience Information Succession 11

Harvard Business Review

APRIL 27, 2012

These are all pretty common assertions in modern business/tech journalism and management literature. Business models are being transformed, lives are being upended, vast new horizons of possibility opened up. Or something like that. Then there's another view, which I heard from author Neal Stephenson in an MIT lecture hall last week.

Stephenson 19

Stephenson Innovation Biotechnology eBook 19

Harvard Business Review

MARCH 1, 2011

And biotechnology and medical devices are among the leading areas for venture capital funding. Will hospital managers search for efficiency, or continue to manage volume? Will doctors think about care management as equally valuable as rescue of the sick? Here, then, is the conundrum.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

DECEMBER 30, 2011

That was the question Todd Pierce asked himself in 2006 after years of experimenting with the full menu of trainings, meetings, and competency models in his capacity as CIO of biotechnology giant Genentech. I remember sitting there and saying, 'There's got to be a another way.'".

Development 21

Development Biotechnology CIO Short-term 21

Harvard Business Review

MAY 2, 2011

Another CEO of a fast-growing biotechnology venture, a Chinese-American entrepreneur, added that he wanted his company to be perceived as American rather than as Chinese. Haiyan Wang is the managing partner of the China India Institute. "Most technology ventures in China are of the C2C variety, i.e., Copy-To-China.

Globalization 15

Globalization Marketing Venture Capitalist Biotechnology 15

Harvard Business Review

JUNE 21, 2013

Our research found they are one of the regions struggling most to establish great talent management practices, among them hiring, assessing, rewarding, and firing talent. If, in addition, companies are managing their underperformers out poorly, the costs rise even further. Global business Talent management'

Telecommunications 13

Telecommunications Health Care Talent Management Biotechnology 13

Harvard Business Review

FEBRUARY 17, 2011

The reason for the interest in in part because the industry has suffered from poor returns on investment over the last decade; indeed, some sectors, including biotechnology, report negative aggregate returns. China and India, in particular, offer attractive liquidity and investment opportunities VCs haven't seen for a while.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. While recruitment errors happen, the performance evaluation highlights those shortcomings and gives the manager and the employee a chance to correct the situation.

Company 13

Company Pharmaceuticals Biotechnology Short-term 13

Harvard Business Review

MARCH 13, 2012

When I was teaching at Peking University, for example, one of my fellow professors monitored an experiment in which the Chinese government gave local villagers the rights to manage a forest. Is it possible that local funding could help bolster tourism in Florida, biotechnology in California, publishing in New York, and agriculture in Iowa?

Biotechnology 12

Biotechnology Real Estate Tourism Banking 12

Harvard Business Review

MARCH 2, 2012

It started 30 years ago with the progressive and unusual step (for that time) of shifting from local nationals as country managers to global leaders from other countries. French pharmaceutical company Sanofi recently acquired Boston-based Genzyme to tap into America's intellectual capital in biotechnology.

Competitive Advantage 16

Competitive Advantage Globalization Development Intellectual Capital 16

Harvard Business Review

SEPTEMBER 21, 2018

In contrast, 70% of respondents think their boards have effective processes for staying current on the company; 69% for compliance; 66% for financial planning; and 55% for risk management — although we should note that managing risks is a crucial consideration when pursuing innovation.

Innovation 14

Innovation Short-term Telecommunications Long-term 14

Harvard Business Review

MAY 7, 2018

She was on the legal compliance team at a fast-growing biotechnology company. They respected that her role was to help manage the company’s legal risk, but she had a tendency to shoot down ideas and take a conservative stance on gray areas, leaving the marketing group feeling demoralized. Do You Really Need to Hold That Meeting?

Restructuring 15

Restructuring How To Compliance Biotechnology 15

Harvard Business Review

JUNE 3, 2013

What kind of signal did this choice send to P&G''s top managers? Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? Using data from the 2012 survey, we also found that boards gave their companies'' very poor grades on talent management.

Succession 9

Succession Telecommunications Biotechnology Real Estate 9

Harvard Business Review

JULY 16, 2013

And 43% cited technology expertise, HR-talent management, international-global expertise, and succession planning as the skills missing most on their boards. The industry with the greatest skills gap was IT & telecommunications, whose boards are in serious need of international-global expertise and HR-talent management.

Telecommunications 10

Telecommunications Health Care Biotechnology Real Estate 10

Harvard Business Review

MARCH 17, 2014

Without those, the institutions managing the billions of sector dollars won’t be able accurately to assess the risks they are taking and, more important, the returns, both financial and social, they hope to generate. We allowed microfinance and the venture capital industry the time and space to develop over a few decades.

Development 11

Development Microfinance Biotechnology Exit Strategy 11

Harvard Business Review

FEBRUARY 22, 2013

Having observed management teams for decades as a mutual fund and portfolio manager, I have watched numerous companies vanish after a disastrous launch of a product or service. Cephalon's IPO was in 1991, part of the second wave of biotechnology companies to sell shares to the public. What do you do next?

Productivity 9

Productivity Products Biotechnology IPO 9

Harvard Business Review

JUNE 5, 2014

Without neural implants or biotechnological grafting, you will never be smarter or more computationally competent than I am. You will be managing people and their machines, as well as machines and their people. We are all cyborgs now. But I must point out the obvious. Put together.

Biotechnology 12

Biotechnology Technology Class Hedge 12

Harvard Business Review

SEPTEMBER 14, 2011

Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines. facility in Cambridge Science Park. Polycentric innovation won't work in organizations that promote groupthink.

Globalization 11

Globalization Innovation Decentralization Chemicals 11

Harvard Business Review

OCTOBER 22, 2013

This industry is fueled by advances in chemistry and biotechnology that allow the use of pharmacological and cosmetic therapies in areas where, earlier, surgical intervention was needed. Cosmeceuticals , for example, is the new industry emerging from the convergence of the personal care/cosmetic and pharmaceutical industries.

Skills 11

Skills Power Six Sigma Disruptive Innovation 11

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Risk and outcomes, as the scenario plays out, will be managed by predictive models, which are powered by machine learning algorithms that will improve their accuracy rates over time.

Health Care 9

Health Care Pharmaceuticals Information Technology Supply Chain 9

Harvard Business Review

FEBRUARY 22, 2017

pharmaceuticals, biotechnology & life sciences, health care equipment and services); Industrials (e.g., ” Boards can hold executive management accountable for evaluating current cybersecurity risks and maintaining response plans by making cybersecurity debriefings a regular agenda item at board meetings.

Telecommunications 8

Telecommunications Health Care Contingency Plans Biotechnology 8

Harvard Business Review

JUNE 4, 2018

For instance, a curriculum designed for a local manufacturer of medical supplies and food safety products includes several courses in electronics, welding, lean, torque certification, robotics/programmable logic controllers, precision machining, and management. “Students need to understand tomorrow’s skills, not yesterday’s.”

Education 8

Education Company Biotechnology Human Capital 8